Corient Private Wealth
ADPT icon

Corient Private Wealth’s Adaptive Biotechnologies ADPT Stock Holding History

Corient Private Wealth’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,201
Closed -$1,000K – 3045
2026
Q1 		$1,000K Buy
72,201
+293
+0.4% +$4.67K ﹤0.01% 1665
2025
Q4 		$1.17M Buy
71,908
+2,347
+3% +$38.3K ﹤0.01% 1430
2025
Q3 		$1.04M Sell
69,561
-5,835
-8% -$71.1K ﹤0.01% 1409
2025
Q2 		$878K Sell
75,396
-1,441
-2% -$13.1K ﹤0.01% 1425
2025
Q1 		$571K Sell
76,837
-10,811
-12% -$83.1K ﹤0.01% 1538
2024
Q4 		$525K Buy
87,648
+643
+0.7% +$3.54K ﹤0.01% 1589
2024
Q3 		$445K Buy
87,005
+5,261
+6% +$22.9K ﹤0.01% 1802
2024
Q2 		$296K Buy
81,744
+2,043
+3% +$6.49K ﹤0.01% 1928
2024
Q1 		$256K Sell
79,701
-3,223
-4% -$12.5K ﹤0.01% 1980
2023
Q4 		$406K Sell
82,924
-47,093
-36% -$215K ﹤0.01% 1719
2023
Q3 		$709K Sell
130,017
-10,774
-8% -$71.2K ﹤0.01% 1316
2023
Q2 		$945K Buy
140,791
+67,288
+92% +$500K ﹤0.01% 1180
2023
Q1 		$649K Buy
73,503
+1,383
+2% +$12.2K ﹤0.01% 1269
2022
Q4 		$551K Buy
+72,120
New +$561K ﹤0.01% 1108

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Corient Private Wealth's ADPT Position: Q2 2026 in Review

Corient Private Wealth sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 72,201 shares — an estimated $1,000K sold.

Corient Private Wealth first reported a position in ADPT in Q4 2022 and held it in 14 quarters. The position peaked at $1.17M in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Corient Private Wealth reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • Corient Private Wealth sold 72,201 Adaptive Biotechnologies shares in Q2 2026, an estimated $1,000K.
  • Corient Private Wealth first reported a position in Adaptive Biotechnologies in Q4 2022 and held it in 14 quarters.
  • Corient Private Wealth's Adaptive Biotechnologies position peaked at $1.17M in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.